Dosage forms

Solid dosage forms

Tablets

  • Multilayer tablets
  • Film and sugar coated tablets
  • MR tablets (modified release)
  • IR tablets (immediate release)
  • Enteric-coated tablets
  • ODT tablets (orally disintegrating tablets)
  • Vaginal tablets
  • Effervescent tablets
  • Chewable tablets

Hard capsules

  • Filled with: powders, pellets, granulate, granulate + tablet

Soft gelatin capsules

Liquid dosage forms

Oral liquids

  • Syrups
  • Suspensions
  • Solutions
  • Drops

Nasal drops and gels

Eye drops

  • Single and multi-dosage products
  • Solutions
  • Suspensions
  • Products with no preservatives
Sterile injections and infusions

Solutions and emulsions in glass ampoules and vials

LDPE small volumes
parenteral (BFS)

LDPE large volumes
parenteral (BFS)

Pre-filled syringes

Semisolid dosage forms

Topical products and cosmetics

  • Gels
  • Emulsions
  • Ointments
  • Shampoos
  • Antifungal nail polish

Where we are

Starogard Gdanski

LVP
SVP

Specialization: solid dosage forms, sterile
injections & infusions

Sieradz

Specialization: pediatric medicines, vitamins
& food supplements

Duchnice

Specialization: cephalosporin

Warsaw

Specialization: ophthalmic &
parenteral products

Nowa deba

Specialization: solid dosage forms,
high potent

About us

CMO
Polpharma B2B
Polpharma Group

CMO is a part of Polpharma B2B Unit. We offer customized contract manufacturing services with full analytical support in our European cGMP-compliant production plants.

We have broad experience in production of medicinal products (Rx and OTC), dietary supplements, medical devices and cosmetics.

Our values are: QUALITY, STABILITY, RELIABILITY, RESPONSIVENESS

News

31 May 2022
CPhI MEA 2019
Meet us at CPhI MEA 2019, September 16th- September 18th.
27 October 2021
Polpharma B2B at CPhl Worldwide 2021
Meet our team in Milan, Italy during CPHI 9-11.11.202
22 October 2019
Drug safety cannot be guaranteed without access to active substances!
Doctor Wojciech Kuzmierkiewicz, President of the Management Board of the Polpharma Scientific Foundation, delivered a…